Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Janux Therapeutics Inc (JANX)

Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Janux Therapeutics Inc 10955 Vista Sorrento Parkway Suite 200 San Diego CA 92130 USA

www.januxrx.com P: 858-751-4493

Description:

Janux Therapeutics Inc. is a biopharmaceutical company. It involved in developing novel T cell engager immunotherapies. Janux Therapeutics Inc. is based in LA JOLLA, Calif.

Key Statistics

Overview:

Market Capitalization, $K 2,192,260
Enterprise Value, $K 2,173,050
Shares Outstanding, K 51,851
Annual Sales, $ 8,080 K
Annual Net Income, $ -58,290 K
Last Quarter Sales, $ 1,250 K
Last Quarter Net Income, $ -14,760 K
EBIT, $ -72,860 K
EBITDA, $ -78,590 K
60-Month Beta 3.58
% of Insider Shareholders 35.40%
% of Institutional Shareholders 75.39%
Float, K 33,496
% Float 64.60%
Short Volume Ratio 0.57

Growth:

1-Year Return 235.44%
3-Year Return 58.06%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.30 on 05/07/24
Next Earnings Date 08/13/24
Earnings Per Share ttm -1.22
EPS Growth vs. Prev Qtr -20.00%
EPS Growth vs. Prev Year 28.57%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

JANX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -13.49%
Return-on-Assets % -12.37%
Profit Margin % -721.41%
Debt/Equity 0.00
Price/Sales 266.54
Price/Cash Flow N/A
Price/Book 3.29
Book Value/Share 12.65
Interest Coverage -1.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar